Drug Promotion, Quality and Patient Safety

Presented opening remarks at the symposium on “Drug Promotion, Quality and Patient Safety”. The aim of the symposium was to provide researchers and policy-makers an opportunity to explore drug promotion regulation in terms of quality of information and impacts on patient safety. It also included discussion of the results of a comparative study examining the quality of information provided to primary care physicians by pharmaceutical sales representatives in the United States, France and Canada. November 29, 2010, Toronto, Ontario